tradingkey.logo

Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut

ReutersDec 11, 2025 4:34 PM

Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut

Stock indicated to open at $18.75 apiece vs $18.50 IPO price

Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million

The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday

Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS

LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states

Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI